CP-122288

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameCP-122288

Drug Alias NameCP-122288

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 1b (5-HT1b) receptor agonistsSerotonin 1d (5-HT1d) receptor agonists

TargetsSerotonin 1b (5-HT1b) receptorSerotonin 1d (5-HT1d) receptor

Therapy Area/IndicationsMigraine Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsMigraine Disorders

ATC CodeN/A